US Patent Issued to ADD2LIFE on June 2 for "Lactic acid bacteria strain-antibacterial peptides produced by said strain and related pharmaceutical compositions" (French, Algerian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,827, issued on June 2, was assigned to ADD2LIFE GMBH (Wiener Neustadt, Austria).

"Lactic acid bacteria strain-antibacterial peptides produced by said strain and related pharmaceutical compositions" was invented by Rabah Boukherroub (Villeneuve d'Ascq, France), Djamel Drider (Roubaix, France), Noura Hazime (Villeneuve d'Ascq, France), Yanath Belguesmia (Lille, France) and Kamel Bendjeddou (Bejaia, Algeria).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Lactobacillus paracasei strain deposited at the CNCM under reference number CNCM I-5369. A mixture of the peptides having the following sequences: (SEQ ID NO 1), (SEQ ID NO 2), (SEQ ID NO 3), (SEQ ID N...